Novel mutations in the guanosine triphosphate cyclohydrolase 1 gene associated with DYT5 dystonia
- PMID: 17101830
- DOI: 10.1001/archneur.63.11.1605
Novel mutations in the guanosine triphosphate cyclohydrolase 1 gene associated with DYT5 dystonia
Abstract
Objectives: To better understand the relationship between mutation of the guanosine triphosphate cyclohydrolase I (GCH1) gene and the etiology of DYT5 dystonia and to accumulate data on the mutation in the Japanese population for genetic diagnosis of the disease.
Setting: Japanese population. Patients Eight Japanese patients with suspected DYT5 dystonia were analyzed. Intervention Direct genomic sequencing of 6 exons of GCH1 was performed.
Main outcome measures: For patients who did not exhibit any abnormality in the sequence analysis, the possibility of exon deletions was examined. In cases for which cerebrospinal fluid was available, the concentrations of neopterin and biopterin were measured as an index of GCH1 enzyme activity.
Results: In 2 patients, we found a new T106I mutation in exon 1 of GCH1, a position involved in the helix-turn-helix structure of the enzyme. In the third patient, we found a new mutation (a 15-base pair nucleotide deletion) in exon 5 that may cause a frameshift involving the active site. In the fourth patient, we detected a known nucleotide G>A substitution in the splice site of intron 5, which has been reported to produce exon 5-skipped messenger RNA. The concentrations of both neopterin and biopterin in the cerebrospinal fluid of the third and fourth patients were markedly lower than the normal range, indicating that the GCH1 enzyme was functionally abnormal in these mutations. Gene dosage analysis showed that the fifth patient had a deletion of both exon 3 and exon 4, whereas the sixth patient had a deletion of exon 3.
Conclusions: We found several novel, as well as known, GCH1 mutations in Japanese patients with DYT5 dystonia. In some of them, the GCH1 enzyme activity was proved to be impaired.
Similar articles
-
A new mutation (Thr106Ile) of the GTP cyclohydrolase 1 gene associated with DYT5 dystonia (Segawa disease).Mov Disord. 2005 Aug;20(8):1083-4. doi: 10.1002/mds.20490. Mov Disord. 2005. PMID: 15852365 No abstract available.
-
A case of late-onset Segawa syndrome (autosomal dominant dopa-responsive dystonia) with a novel mutation of the GTP-cyclohydrase I (GCH1) gene.Clin Neurol Neurosurg. 2006 Dec;108(8):784-6. doi: 10.1016/j.clineuro.2005.10.004. Epub 2005 Nov 14. Clin Neurol Neurosurg. 2006. PMID: 16289769
-
GTP-cyclohydrolase I gene mutations in hereditary progressive amd dopa-responsive dystonia.Ann Neurol. 1996 May;39(5):609-17. doi: 10.1002/ana.410390510. Ann Neurol. 1996. PMID: 8619546
-
Clinical genetics of functionally mild non-coding GTP cyclohydrolase 1 (GCH1) polymorphisms modulating pain and cardiovascular risk.Mutat Res. 2008 Sep-Oct;659(3):195-201. doi: 10.1016/j.mrrev.2008.04.007. Epub 2008 Apr 26. Mutat Res. 2008. PMID: 18515178 Review.
-
[Segawa's disease].Rinsho Shinkeigaku. 2000 Dec;40(12):1284-6. Rinsho Shinkeigaku. 2000. PMID: 11464480 Review. Japanese.
Cited by
-
Urinary neopterin and phenylalanine loading test as tools for the biochemical diagnosis of segawa disease.JIMD Rep. 2013;7:67-75. doi: 10.1007/8904_2012_144. Epub 2012 Apr 18. JIMD Rep. 2013. PMID: 23430498 Free PMC article.
-
Consensus guideline for the diagnosis and treatment of tetrahydrobiopterin (BH4) deficiencies.Orphanet J Rare Dis. 2020 May 26;15(1):126. doi: 10.1186/s13023-020-01379-8. Orphanet J Rare Dis. 2020. PMID: 32456656 Free PMC article. Review.
-
Segawa syndrome due to mutation Q89X in the GCH1 gene: a possible founder effect in Córdoba (southern Spain).J Neurol. 2009 Nov;256(11):1816-24. doi: 10.1007/s00415-009-5198-z. Epub 2009 Jun 16. J Neurol. 2009. PMID: 19533203
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases